IMPACT OF LOCOREGIONAL THERAPIES ON SURVIVAL IN HCC PATIENTS LISTED FOR LIVER TRANSPLANTATION

被引：0
|
作者：
Gyoeri, Georg [1 ]
Felsenreich, Moritz [1 ]
Silberhumer, Gerd [1 ]
Soliman, Thomas [1 ]
Sieghart, Wolfgang [2 ]
Berlakovich, Gabriela A. [1 ]
机构：
[1] Med Univ Vienna, Dept Transplantat, Vienna, Austria
[2] Med Univ Vienna, Dept Hepatol, Vienna, Austria
来源：
TRANSPLANT INTERNATIONAL | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O239
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [21] Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma
    Minzhi Xing
    Sonali Sakaria
    Renumathy Dhanasekaran
    Samir Parekh
    James Spivey
    Stuart J. Knechtle
    Di Zhang
    Hyun S. Kim
    CardioVascular and Interventional Radiology, 2017, 40 : 410 - 420
  • [22] Impact of locoregional therapies in patients on the waiting list for liver transplantation. A review of 123 patients transplanted at a single center
    Slim, Abdallah
    Giacomoni, Alessandro
    Lauterio, Andrea
    Dorobantu, Bogdan
    Mangoni, Iacopo
    Mihaylov, Pavel
    Donadon, Matteo
    Pirotta, Vincenzo
    De Carlis, Luciano
    TRANSPLANT INTERNATIONAL, 2007, 20 : 284 - 284
  • [23] Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation
    Russo, MW
    Lapointe-Rudow, D
    Kinkhabwala, M
    Emond, J
    Brown, RS
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (03) : 427 - 431
  • [24] Which Is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?
    Lai, Quirino
    Vitale, Alessandro
    Rossi, Massimo
    Cillo, Umberto
    Lerut, Jan
    ANNALS OF SURGERY, 2018, 268 (06) : E56 - E57
  • [25] IS COMPLETE NECROSIS OF HCC BY LOCOREGIONAL THERAPY ESSENTIAL PRIOR TO LIVER TRANSPLANTATION?
    Brubaker, William D.
    Chang, Matthew S.
    Halazun, Karim J.
    Lim, Emerson
    Siegel, Abby
    Kato, Tomoaki
    Brown, Robert S.
    Emond, Jean C.
    HEPATOLOGY, 2010, 52 (04) : 1151A - 1152A
  • [26] Outcome of Locoregional Therapy for Hepatocellular Carcinoma (HCC) Before Liver Transplantation
    El-Gazzaz, Galal
    Ibarra, Rafael A.
    Sanabria, Juan
    Menon, K. V. Narayanan
    Miller, Charles M.
    Fung, John J.
    Aucejo, Federico N.
    GASTROENTEROLOGY, 2011, 140 (05) : S961 - S961
  • [27] IMPACT OF BRIDGING THERAPY ON TUMOR RECURRENCE AND SURVIVAL IN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA (HCC)
    Hassett, Molly
    Mantry, Parvez S.
    Mejia, Alejandro
    Weinstein, Jeffrey S.
    Mubarak, Abdullah
    Madani, Bahar
    Cheng, Stephen
    Anthony, Tiffany
    HEPATOLOGY, 2011, 54 : 647A - 647A
  • [28] PROLONGED SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) WITHOUT LIVER TRANSPLANTATION
    Ghoulam, Elie
    Al-Taee, Ahmad
    Di Bisceglie, Adrian M.
    HEPATOLOGY, 2019, 70 : 242A - 243A
  • [29] Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCC
    Foerster, Friedrich
    Mittler, Jens
    Darstein, Felix
    Heise, Michael
    Marquardt, Jens U.
    Woerns, Marcus-Alexander
    Weinmann, Arndt
    Saelter, Lina
    Hoppe-Lotichius, Maria
    Heinrich, Stefan
    Kloeckner, Roman
    Pitton, Michael B.
    Schattenberg, Joern M.
    Sprinzl, Martin F.
    Dueber, Christoph
    Otto, Gerd
    Lang, Hauke
    Galle, Peter R.
    Zimmermann, Tim
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 55 : 57 - 65
  • [30] IMPACT OF BRIDGING THERAPY ON THE SURVIVAL AND RECURRENCE RATE AFTER LIVER TRANSPLANTATION FOR HCC
    Bauschke, A.
    Altendorf-Hofmann, A.
    Kissler, H.
    Malessa, C.
    Settmacher, U.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 39 - 39
12345